US Stock MarketDetailed Quotes

IBRX ImmunityBio

Watchlist
  • 2.710
  • -0.040-1.45%
Close Mar 21 16:00 ET
  • 2.700
  • -0.010-0.37%
Post 20:01 ET
2.31BMarket Cap-4.37P/E (TTM)

ImmunityBio Key Stats

ImmunityBio Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 23.496M--
--2025/Q1-- / 17.498M--
--2024/Q47.552M / 9.505M--
--2024/Q36.106M / 2.925M--
--2024/Q21.047M / 2.525M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 23.496M--
--2025/Q1-- / 17.498M--
--2024/Q47.552M / 9.505M--
--2024/Q36.106M / 2.925M--
--2024/Q21.047M / 2.525M--

Unlock Free Earnings Estimates

ImmunityBio Earnings Reports

Read more

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More